Hydrofarm Holdings Group, Inc.

Report azionario NasdaqCM:HYFM

Capitalizzazione di mercato: US$3.8m

Hydrofarm Holdings Group Crescita futura

Criteri Future verificati 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Hydrofarm Holdings Group.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Machinery crescita degli utili16.7%
Tasso di crescita dei ricavin/a
Rendimento futuro del capitale proprion/a
Copertura analitica

None

Ultimo aggiornamenton/a

Aggiornamenti recenti sulla crescita futura

Recent updates

Articolo di analisi • Aug 13

Little Excitement Around Hydrofarm Holdings Group, Inc.'s (NASDAQ:HYFM) Revenues As Shares Take 27% Pounding

To the annoyance of some shareholders, Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) shares are down a considerable...
Articolo di analisi • Aug 06

Is It Time To Consider Buying Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)?

While Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) might not have the largest market cap around , it received a lot...
Articolo di analisi • May 31

It Looks Like Hydrofarm Holdings Group, Inc.'s (NASDAQ:HYFM) CEO May Expect Their Salary To Be Put Under The Microscope

Key Insights Hydrofarm Holdings Group to hold its Annual General Meeting on 6th of June Salary of US$600.0k is part of...
Articolo di analisi • May 22

A Look At The Fair Value Of Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)

Key Insights Hydrofarm Holdings Group's estimated fair value is US$0.76 based on 2 Stage Free Cash Flow to Equity...
Articolo di analisi • Apr 04

Hydrofarm Holdings Group, Inc.'s (NASDAQ:HYFM) Shares Bounce 37% But Its Business Still Trails The Industry

Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) shareholders would be excited to see that the share price has had a...
Articolo di analisi • Mar 08

Time To Worry? Analysts Just Downgraded Their Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Outlook

The latest analyst coverage could presage a bad day for Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ), with the...
Articolo di analisi • Jan 30

Benign Growth For Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Underpins Its Share Price

When you see that almost half of the companies in the Machinery industry in the United States have price-to-sales...
Seeking Alpha • Jan 29

Hydrofarm: Why I Still Think It Could More Than Double

Summary Hydrofarm stock has decreased since the previous positive perspective article, currently lagging behind other cannabis stocks. The potential delisting by NASDAQ poses a challenge for the company, but a reverse-split could help it meet the minimum price requirement. Despite challenging fundamentals, Hydrofarm has reduced expenses and generated cash flow, with the potential for significant upside in the future. It is a very large position in my model portfolio and could more than double in price in 2024. Read the full article on Seeking Alpha
Articolo di analisi • Aug 14

Time To Worry? Analysts Are Downgrading Their Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Outlook

One thing we could say about the analysts on Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) - they aren't optimistic...
Articolo di analisi • Aug 11

Earnings Update: Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Just Reported And Analysts Are Trimming Their Forecasts

Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) missed earnings with its latest second-quarter results, disappointing...
Seeking Alpha • Sep 11

Hydrofarm: Caution Saves The Day

Summary Hydrofarm has seen a massive share price implosion since its public offering. Last year's dealmaking resulted in just a moderate leverage build up following an equity raise, yet sales and earnings power have fallen through the floor. Shares are speculative at best, at very best. About a year ago I concluded that Hydrofarm Holdings (HYFM) was acquiring value, making relative cheap acquisitions to average down from a high valuation. The company is a listed supplier for vertical farming in the cannabis industry which because of this positioning attracted great interest from investors. The company has been awarded very steep valuations as a result and was averaging down by using its expensive stock/as a currency to average down. Some Background Hydrofarm has actually been around for some four decades already, originally being a supplier to the cottage industry, as it has focused on cannabis and controlled environment agriculture as well in more recent times, promising less need for water, less land, fewer chemicals, less carbon emissions and improved crop yields. The company went public at $20 per share late in 2020, only to rise to $47 per share on the first day of trading, pushing up the valuation to $1.5 billion. This valuation was based on a business which reported a 10% increase in sales to $235 million in 2019, as operating losses came in at $27 million, in part being the result of restructuring charges. Even if we exclude these, the 11% gross margins of the business indicate the inherent limited margins of the business. Revenues rose by an impressive 40% in the first nine months of 2020 as the company managed to post operating profits of $10 million that year. Moreover, momentum was accelerating with third quarter sales up 60% to $97 million as operating profits of $5.5 million indicated a $22 million run rate. With established peer Scotts Miracle-Gro (SMG) growing sales at a more spectacular number, being vastly profitable, it actually traded at a lower sales multiple. Hydrofarm quickly became a momentum name and hit the $100 mark early in 2021, yet by August of last year, shares fell back to $50. This came amidst many moving factors as the company called for 20% organic growth in 2021, the timing of which coincided with the peak in the share price. Fourth quarter revenues grew 62% to $87 million and while the company raised the guidance, now seeing 20-25% organic growth outlook for 2021, EBITDA was only seen at $28-31 million, comparing to a $21 million number posted in 2020. In April, the company reached a $78 million deal to acquire Heavy 16 at relative compelling multiples, as Hydrofarm sold nearly 5 million shares at $59 per share in April to fund this deal and future acquisitions. First quarter sales rose 66% to $111 million, with the organic growth guidance hiked to 30-40% and with the EBITDA guidance hiked to $39 million. The funds raised in April were quickly used as the company acquired a $125 million deal for House & Garden and $187 million deal for Aurora Innovations early in the summer. These three deals cost $400 million, added $140 million in sales and $50 million in EBITDA. Trading at $50 in August, the 45 million shares valued the business at $2.2 billion. These deals should create a more than $500 million business with EBITDA seen around 100 million. Factoring in assumed D&A charges, I pegged realistic operating earnings around $50 million, which created a roadmap for earnings of a dollar per share. That was far from a certainty with many factors still having to play out in the short term, amidst many moving parts (related to the many acquisitions). With earnings power (potentially) around a dollar, and shares trading at $50, the valuation was far too rich to create a compelling situation. All Downhill Shares of Hydrofarm ended 2021 around the $25 mark. Since my take last year, the company kept on pursuing acquisitions, which includes an $83 million deal for Greenstar Plant Products in August, as the company updated the pro forma sales outlook to $565-$590 million, yet adjusted EBITDA of $80-$90 million, a bit softer than I anticipated. In October, the company reached a $58 million deal to acquire Innovative Growers Equipment, updating the pro forma outlook bit to account for recent dealmaking. Shares fell to the teens when the company posted its full year results in March of this year. The 2021 results were hard to read into as the company announced many deals during the year and hence the outlook is much more informative. The company guided for 2022 sales between $575 and $615 million, yet adjusted EBITDA is seen at just $63-$74 million, far below the pro forma EBITDA numbers communicated in 2021 and my $100 million estimate based on the dealmaking spree in 2020, indicating the many deals have not lived up to expectations. That was still manageable as net debt only stood around a hundred million, still a manageable amount. With D&A charges trending at $25 million and factoring in a $10 million run-rate in terms of stock-based compensation, adjusted EBIT runs around $30-$40 million. This still resulted in potential earnings power of around half a dollar per share, yet momentum was clearly on the soft side. The problem is that momentum quickly went downhill as the company cut the sales guidance to a midpoint of just $500 million following the first quarter results, with EBITDA seen at a midpoint of $50 million. This is dismal as a soft first quarter made that the company posted real economic losses, resulting in a modest build up in debt as the degree of the revenue shortfall (about $95 million in just three months time) is utterly shocking as shares fell to the mid single digits in response to the results.
Articolo di analisi • Aug 03

What You Need To Know About The Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Analyst Downgrade Today

Today is shaping up negative for Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) shareholders, with the analysts...
Seeking Alpha • May 12

Hydrofarm In A Turning Point, But We Are Still Not Convinced

Still positive in the long term but not very optimistic in the near term. Despite a favourable inflationary environment, the company is not passing cost increases. Guidance down compared to the Q4/FY 2021 outlook.
Articolo di analisi • May 11

Estimating The Fair Value Of Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)

In this article we are going to estimate the intrinsic value of Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) by...
Articolo di analisi • Jan 26

An Intrinsic Calculation For Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Suggests It's 49% Undervalued

How far off is Hydrofarm Holdings Group, Inc. ( NASDAQ:HYFM ) from its intrinsic value? Using the most recent financial...
Seeking Alpha • Jan 24

Hydrofarm: Top Player In Sector With Near-Term Vulnerabilities

Hydrofarm grew at a CAGR of 33% from FY17 to FY22, reaching a breakeven point in FY21. CEA industry will continue to grow steadily, especially in a scenario of worsening climate conditions. A FY21 characterized by M&A transactions totalling $615 million and goodwill for $297 million.

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Hydrofarm Holdings Group non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

NasdaqCM:HYFM - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/2026122-290-4-3N/A
12/31/2025134-290-15-14N/A
9/30/2025146-65-8-7N/A
6/30/2025161-62-13-12N/A
3/31/2025177-68-11-10N/A
12/31/2024190-67-30N/A
9/30/2024200-64-7-5N/A
6/30/2024210-7158N/A
3/31/2024219-611014N/A
12/31/2023227-6537N/A
9/30/2023241-851015N/A
6/30/2023261-89916N/A
3/31/2023295-2791623N/A
12/31/2022345-2851422N/A
9/30/2022393-261-22-12N/A
6/30/2022443-220-47-37N/A
3/31/2022479-15-60-53N/A
12/31/202147913-50-45N/A
9/30/202145614-58-55N/A
6/30/2021429-1-46-44N/A
3/31/2021387-1-48-46N/A
12/31/2020342-10-46-45N/A
9/30/2020309-18-10-10N/A
6/30/2020272-28-8-7N/A
3/31/2020242-37-12-11N/A
12/31/2019235-40N/A-13N/A
12/31/2018212-33N/A4N/A
12/31/2017202-83N/A-18N/A
12/31/201627316N/A9N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista HYFM è superiore al tasso di risparmio ( 3.5% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di HYFM cresceranno più velocemente del mercato US

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di HYFM cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di HYFM cresceranno più rapidamente del mercato US.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di HYFM cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di HYFM è previsto essere elevato tra 3 anni

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/07/12 01:41
Prezzo dell'azione a fine giornata2026/07/10 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Hydrofarm Holdings Group, Inc. è coperta da 7 analisti. 0 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Nicole DeBlaseDeutsche Bank
Andrea TeixeiraJ.P. Morgan
William CarterStifel, Equities Research